GSK's antigen-specific cancer immunotherapy programme: Pilot results leading to Phase III clinical development
Year: 2007
Type: review
Source: Vaccine
Authors: Vincent G. Brichard, Diane Lejeune
Institution: GlaxoSmithKline (Belgium)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2047127667
